Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth K C Man

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
JAMA Psychiatry|January 25, 2023
Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 PandemicHao Luo, Wallis C Y Lau, Yi Chai, et al.
The Lancet Regional Health. Europe|December 27, 2024
Maternal and pregnancy factors contributing to the association between area deprivation and infant mortality in England: a retrospective cohort studyFrederick K Ho, Max Allan, Hui Shao, et al.
Journal of the American College of Cardiology|April 15, 2026
Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes MellitusFan Bu, Ruopeng Wu, Anna Ostropolets, et al.
Journal of Attention Disorders|February 23, 2024
Methylphenidate and Sleep Difficulties in Children and Adolescents With ADHD: Results From the 2-Year Naturalistic Pharmacovigilance ADDUCE StudyAlexander Häge, Kenneth K C Man, Sarah K Inglis, et al.
The Lancet. Psychiatry|September 6, 2024
Psychotropic drug prescribing before and during the COVID-19 pandemic among people with depressive and anxiety disorders: a multinational network studyHao Luo, Yi Chai, Sijia Li, et al.
The Lancet. Psychiatry|March 23, 2023
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) studyKenneth K C Man, Alexander Häge, Tobias Banaschewski, et al.
Schizophrenia Research|April 17, 2020
Antipsychotic drug use in pregnancy: A multinational study from ten countriesJohan Reutfors, Carolyn E Cesta, Jacqueline M Cohen, et al.
Clinical Pharmacology and Therapeutics|August 18, 2025
Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real-World Databases from Korea and TaiwanHwa Yeon Ko, Philip C M Au, Michael Chun-Yuan Cheng, et al.
BMC Medicine|February 20, 2026
ADHD and adherence to antihypertensive medication treatment: a multinational cohort studyHonghui Yao, Yiling Zhou, Lin Li, et al.
Journal of Attention Disorders|February 17, 2024
The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) ProjectSara Carucci, Alessandro Zuddas, Angelico Lampis, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
JAMA Psychiatry|January 25, 2023
Rates of Antipsychotic Drug Prescribing Among People Living With Dementia During the COVID-19 PandemicHao Luo, Wallis C Y Lau, Yi Chai, et al.
The Lancet Regional Health. Europe|December 27, 2024
Maternal and pregnancy factors contributing to the association between area deprivation and infant mortality in England: a retrospective cohort studyFrederick K Ho, Max Allan, Hui Shao, et al.
Journal of the American College of Cardiology|April 15, 2026
Comparative Cardiovascular Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors in Diabetes MellitusFan Bu, Ruopeng Wu, Anna Ostropolets, et al.
Journal of Attention Disorders|February 23, 2024
Methylphenidate and Sleep Difficulties in Children and Adolescents With ADHD: Results From the 2-Year Naturalistic Pharmacovigilance ADDUCE StudyAlexander Häge, Kenneth K C Man, Sarah K Inglis, et al.
The Lancet. Psychiatry|September 6, 2024
Psychotropic drug prescribing before and during the COVID-19 pandemic among people with depressive and anxiety disorders: a multinational network studyHao Luo, Yi Chai, Sijia Li, et al.
The Lancet. Psychiatry|March 23, 2023
Long-term safety of methylphenidate in children and adolescents with ADHD: 2-year outcomes of the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) studyKenneth K C Man, Alexander Häge, Tobias Banaschewski, et al.
Schizophrenia Research|April 17, 2020
Antipsychotic drug use in pregnancy: A multinational study from ten countriesJohan Reutfors, Carolyn E Cesta, Jacqueline M Cohen, et al.
Clinical Pharmacology and Therapeutics|August 18, 2025
Emulating Six Cardiovascular Outcome Trials of Antidiabetic Drugs in Individuals with Type 2 Diabetes: Analyses Based on Real-World Databases from Korea and TaiwanHwa Yeon Ko, Philip C M Au, Michael Chun-Yuan Cheng, et al.
BMC Medicine|February 20, 2026
ADHD and adherence to antihypertensive medication treatment: a multinational cohort studyHonghui Yao, Yiling Zhou, Lin Li, et al.
Journal of Attention Disorders|February 17, 2024
The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects (ADDUCE) ProjectSara Carucci, Alessandro Zuddas, Angelico Lampis, et al.
Pageof 16